C

Caliway Biopharmaceuticals Co Ltd
TWSE:6919

Watchlist Manager
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Watchlist
Price: 170 TWD 1.49%
Market Cap: 263.7B TWD

Intrinsic Value

The intrinsic value of one Caliway Biopharmaceuticals Co Ltd stock under the Base Case scenario is hidden TWD. Compared to the current market price of 170 TWD, Caliway Biopharmaceuticals Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Caliway Biopharmaceuticals Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Caliway Biopharmaceuticals Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Caliway Biopharmaceuticals Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Caliway Biopharmaceuticals Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Caliway Biopharmaceuticals Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Caliway Biopharmaceuticals Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Caliway Biopharmaceuticals Co Ltd.

Explain Valuation
Compare Caliway Biopharmaceuticals Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Caliway Biopharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Caliway Biopharmaceuticals Co Ltd

Current Assets 6.6B
Receivables 2.9m
Other Current Assets 6.6B
Non-Current Assets 2.8B
Long-Term Investments 2.8B
PP&E 53m
Other Non-Current Assets 7m
Current Liabilities 58m
Accounts Payable 1.1m
Accrued Liabilities 42m
Other Current Liabilities 14.9m
Non-Current Liabilities 20m
Other Non-Current Liabilities 20m
Efficiency

Free Cash Flow Analysis
Caliway Biopharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Caliway Biopharmaceuticals Co Ltd

Revenue
34.6m TWD
Cost of Revenue
-10.6m TWD
Gross Profit
23.9m TWD
Operating Expenses
-738.9m TWD
Operating Income
-715m TWD
Other Expenses
226.3m TWD
Net Income
-488.7m TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Caliway Biopharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Caliway Biopharmaceuticals Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Caliway Biopharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Caliway Biopharmaceuticals Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Caliway Biopharmaceuticals Co Ltd

Wall Street analysts forecast Caliway Biopharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Caliway Biopharmaceuticals Co Ltd is 244.8 TWD with a low forecast of 242.4 TWD and a high forecast of 252 TWD.

Lowest
Price Target
242.4 TWD
43% Upside
Average
Price Target
244.8 TWD
44% Upside
Highest
Price Target
252 TWD
48% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Caliway Biopharmaceuticals Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Caliway Biopharmaceuticals Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Caliway Biopharmaceuticals Co Ltd stock?

The intrinsic value of one Caliway Biopharmaceuticals Co Ltd stock under the Base Case scenario is hidden TWD.

Is Caliway Biopharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 170 TWD, Caliway Biopharmaceuticals Co Ltd is hidden .

Back to Top